| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/04/2003 | WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases |
| 09/04/2003 | WO2003072060A2 Polypeptide formulation |
| 09/04/2003 | WO2003072036A2 Treatment methods using anti-cd22 antibodies |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003072029A2 Methods of extending corneal graft survival |
| 09/04/2003 | WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | WO2003072026A2 Method of reducing and treating uvb-induced immunosuppression |
| 09/04/2003 | WO2003064472A3 Treatment of ms with goat serum |
| 09/04/2003 | WO2003053462A3 Staphylococcus aureus exopolysaccharide and process |
| 09/04/2003 | WO2003048334A3 Immunocytokines with modulated selectivity |
| 09/04/2003 | WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors |
| 09/04/2003 | WO2003033681A3 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 09/04/2003 | WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/04/2003 | WO2003025151A3 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 09/04/2003 | WO2003022867A3 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag |
| 09/04/2003 | WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 09/04/2003 | WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 09/04/2003 | WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof |
| 09/04/2003 | WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same |
| 09/04/2003 | WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 09/04/2003 | WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 09/04/2003 | WO2002045708A3 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | US20030167502 Human monoclonal antibodies to dendritic cells |
| 09/04/2003 | US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166854 Allelic variant of human STAT3 |
| 09/04/2003 | US20030166853 Mucin peptide with immunoenhancing properties |
| 09/04/2003 | US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
| 09/04/2003 | US20030166837 Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof |
| 09/04/2003 | US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166723 Gamma-linolenic acid, di-homo-gamma-linolenic acid and derivatives |
| 09/04/2003 | US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 09/04/2003 | US20030166691 Phenylalanine derivatives |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166682 Comprising reacting 4-(4-Hydroxy-1-butynyl)-alpha, alpha-dimethylbenzeneacetic acid methyl ester with a copper and/or silver compound in the presence of palladium or a compound thereof |
| 09/04/2003 | US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation |
| 09/04/2003 | US20030166652 Chemical compounds |
| 09/04/2003 | US20030166647 Nitrogen compounds such as 5-(4-(Benzyloxy)benzyl)-5-methyl-2, 4,6(1H,3H,5H)-pyrimidinetrione, used as enzyme inhibitors, used as antiinflammatory agents |
| 09/04/2003 | US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists |
| 09/04/2003 | US20030166630 Amino acid derivatives and their use as medicines |
| 09/04/2003 | US20030166622 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents |
| 09/04/2003 | US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds |
| 09/04/2003 | US20030166609 Medicine containing polysacccharide substances for activating apoptosis |
| 09/04/2003 | US20030166599 Uses of tgap7 for the modulation of leucocyte activation |
| 09/04/2003 | US20030166588 Splice-region antisense composition and method |
| 09/04/2003 | US20030166587 Compounds and methods for modulating activation of NF-kB |
| 09/04/2003 | US20030166585 Substituted tetracycline compounds as synergistic antifungal agents |
| 09/04/2003 | US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/04/2003 | US20030166568 Organic compounds |
| 09/04/2003 | US20030166565 CD antigens; for regulating inflammation; nuclear magnetic resonance; drug screening |
| 09/04/2003 | US20030166562 Treatment for asthma or allergies |
| 09/04/2003 | US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions |
| 09/04/2003 | US20030166556 Immunoregulator |
| 09/04/2003 | US20030166546 Uses of THANK, a TNF homologue that activates apoptosis |
| 09/04/2003 | US20030166542 Systemic immune response induced by mucosal administration of lipid-tailed polypeptides without adjuvant |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes, |
| 09/04/2003 | US20030166531 Methods for modulating an immune response comprising contacting a cell with an agent that modulates the interaction between CTLA4 and PP2AA via modulating the lysine rich motif of CTLA4. The invention further provides methods |
| 09/04/2003 | US20030166530 Conjugate heat shock protein-binding peptides |
| 09/04/2003 | US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/04/2003 | US20030166524 Therapeutic uses of IL-1 receptor antagonist |
| 09/04/2003 | US20030166517 Galenical formulations |
| 09/04/2003 | US20030166300 Growth-related inflammatory and immune response protein |
| 09/04/2003 | US20030166277 Targeted vaccine delivery systems |
| 09/04/2003 | US20030166257 Use of Lactobacillus salivarius |
| 09/04/2003 | US20030166254 Moving promoter distal gene toward a wild-type 3' gene; gene mapping, genetic engineering; an attenuated virus useful for a vaccine |
| 09/04/2003 | US20030166228 Anti-interferon-alpha antibodies |
| 09/04/2003 | US20030166164 IL-17 like molecules and uses thereof |
| 09/04/2003 | US20030166163 Immunocytokines with modulated selectivity |
| 09/04/2003 | US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all |
| 09/04/2003 | US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases |
| 09/04/2003 | US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 09/04/2003 | US20030166044 Novel proteins |
| 09/04/2003 | US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy |
| 09/04/2003 | US20030166016 Assay methods for cyclin dependent kinases |
| 09/04/2003 | US20030165892 Unigene unidirectional antisense library |
| 09/04/2003 | US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry |
| 09/04/2003 | US20030165558 Antiallergic agent |
| 09/04/2003 | US20030165542 Intensifier of hematopoietic bone marrow stem cells |
| 09/04/2003 | US20030165538 Vaccines, biocatalyst; supplying to respiratory system, mucous membrane; modulate immunology response; fusion protein with spore overcoatings |
| 09/04/2003 | US20030165519 Administering complex of protein taken from original tumor |
| 09/04/2003 | US20030165516 Cytotoxic lumphocyte response; genetic engineering mutants |
| 09/04/2003 | US20030165515 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 09/04/2003 | US20030165514 Modulate immunology response |
| 09/04/2003 | US20030165512 Composition of antigen and glycolipid adjuvant for sublingual administration |
| 09/04/2003 | US20030165499 Compositions and methods for treating psoriasis |
| 09/04/2003 | US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis |
| 09/04/2003 | US20030165478 Stabilized synthetic immunogen delivery system |
| 09/04/2003 | US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents |
| 09/04/2003 | US20030165459 Binding to tumor necrosis factor |
| 09/04/2003 | US20030165444 Lipochroman-6 as no-synthase inhibitor and uses |
| 09/04/2003 | US20030165434 Delivery of polynucleotide agents to the central nervous system |
| 09/04/2003 | CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
| 09/04/2003 | CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |